K-F Chen

Upregulation of the oncoprotein SET determines poor clinical outcomes in hepatocellular carcinoma and shows therapeutic potential

C. Shiau, M. Hung, P. Chu, 2016, Oncogene.

Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells

A. Cheng, C. Shiau, H-l Chen, 2013, Cell Death and Disease.

Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3

Kuen-Feng Chen, A. Cheng, C. Shiau, 2010, Clinical Cancer Research.

Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2A

C. Shiau, M. Hung, P. Chu, 2014, Cell Death and Disease.

SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma

C. Shiau, M. Hung, P. Chu, 2015, Oncogene.

SHP-1 is a negative regulator of epithelial–mesenchymal transition in hepatocellular carcinoma

C. Shiau, M. Hung, P. Chu, 2015, Oncogene.

CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells

A. Cheng, K-F Chen, C-Y Liu, 2010, Oncogene.